According to these results, negative clinical–pathological characteristics are linked to KCNJ2 expression, and more advanced malignant progression of ccRCC is indicated by greater KCNJ2 levels. The gene discussed is KCNJ2; the disease is nonpapillary renal cell carcinoma.